SCHEMBL31466679

SCHEMBL31466679

CC(C)c1cccc(-c2nc3c(c(=O)n(CCCO)c(=O)n3C)n2Cc2ccccc2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPC5 Q9UL62 3/20 0.51
▸ TRPC4 Q9UBN4 2/20 0.51
▸ KCNH2 Q12809 1/20 0.51
▸ BRAF P15056 2/20 0.50
▸ PIK3CG P48736 1/20 0.50
▸ RAB9A P51151 1/20 0.49
▸ ADORA3 P0DMS8 2/20 0.48
▸ HPGD P15428 1/20 0.48
▸ TRPC1 P48995 1/20 0.47
▸ ALDH1A1 P00352 4/20 0.46
▸ MAPT P10636 3/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ ALOX12 P18054 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ PCSK9 Q8NBP7 1/20 0.46
▸ GAA P10253 2/20 0.46
▸ PKM P14618 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16028419 1.00 TRPC5 (0.51) TRPC5TRPC4KCNH2BRAFPIK3CG
SCHEMBL30171360 0.92 TRPC5 (0.51) TRPC5TRPC4KCNH2HPGDTRPC1
SCHEMBL16028606 0.92 TRPC5 (0.51) TRPC5TRPC4KCNH2HPGDTRPC1
SCHEMBL20432632 0.90 ADORA2B (0.53) BRAFRAB9AADORA3HPGDALDH1A1
SCHEMBL16027905 0.90 TRPC5 (0.54) TRPC5TRPC4KCNH2BRAFPIK3CG
SCHEMBL31466662 0.90 TRPC5 (0.54) TRPC5TRPC4KCNH2BRAFPIK3CG
SCHEMBL16028882 0.90 TRPC5 (0.54) TRPC5TRPC4KCNH2BRAFPIK3CG
SCHEMBL31466659 0.90 TRPC5 (0.54) TRPC5TRPC4KCNH2BRAFPIK3CG
SCHEMBL16028313 0.87 TRPC5 (0.52) TRPC5TRPC4KCNH2BRAFPIK3CG
SCHEMBL16027648 0.86 TRPC5 (0.48) TRPC5TRPC4KCNH2TRPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250034143-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF HYDRA BIOSCIENCES, LLC (US) 2025-01-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250034143-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF TRPC5, TRPC7, TRPC4 TRPC5 1/4885TRPC4 3/4885KCNH2 70/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback